Rituximab

In the US, Rituximab (rituximab systemic) is a member of the following drug classes: antirheumatics, CD20 monoclonal antibodies and is used to treat Bullous Pemphigoid, Chronic Lymphocytic Leukemia, Evan's Syndrome, Follicular Lymphoma, Idiopathic Thrombocytopenic Purpura, Microscopic polyangiitis, Non-Hodgkin's Lymphoma, Pemphigoid, Pemphigus, Rheumatoid Arthritis and Wegener's Granulomatosus.

US matches:

• Rituximab


• Rituximab Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC02

CAS registry number (Chemical Abstracts Service)

0174722-31-7

Chemical Formula

C6416-H9874-N1688-O1987-S44

Molecular Weight

143860

Therapeutic Categories

Antineoplastic agent, microtubule inhibitor

Biological response modifier, BRM

Immunomodulator

Monoclonal antibody

Chemical Name

Immunoglobulin G 1 (human-mouse monoclonal IDEC-C2B8 gama 1-chain anti-human antigen CD 20), disulfide with human-mouse monoclonal IDEC-C2B8 kapa-chain, dimer (WHO)

Foreign Names

• Rituximabum (Latin)
• Rituximab (German)
• Rituximab (French)
• Rituximab (Spanish)

Generic Names

• Rituximab (OS: BAN, DCF)
• IDEC 102 (IS: IDEC)
• IDEC C2B8 (IS: IDEC)

Brand Names

• MabThera
  Pfizer, France; Roche, United Arab Emirates; Roche, Albania; Roche, Argentina; Roche, Austria; Roche, Australia; Roche, Aruba; Roche, Bosnia & Herzegowina; Roche, Bangladesh; Roche, Belgium; Roche, Bahrain; Roche, Brazil; Roche, Belarus; Roche, Switzerland; Roche, Chile; Roche, China; Roche, Colombia; Roche, Cuba; Roche, Cyprus; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Dominican Republic; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Finland; Roche, United Kingdom; Roche, Georgia; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Indonesia; Roche, Ireland; Roche, Israel; Roche, India; Roche, Iraq; Roche, Iran; Roche, Iceland; Roche, Italy; Roche, Jamaica; Roche, Jordan; Roche, Kuwait; Roche, Kazakhstan; Roche, Lebanon; Roche, Sri Lanka; Roche, Lithuania; Roche, Luxembourg; Roche, Morocco; Roche, Macedonia; Roche, Mexico; Roche, Malaysia; Roche, Netherlands; Roche, Norway; Roche, Nepal; Roche, New Zealand; Roche, Oman; Roche, Philippines; Roche, Pakistan; Roche, Poland; Roche, Portugal; Roche, Qatar; Roche, Romania; Roche, Serbia; Roche, Russian Federation; Roche, Saudi Arabia; Roche, Slovenia; Roche, Slovakia; Roche, Syria; Roche, Thailand; Roche, Tunisia; Roche, Turkey; Roche, Trinidad & Tobago; Roche, Taiwan; Roche, Ukraine; Roche, Uruguay; Roche, Venezuela; Roche, Yemen; Roche, South Africa; Roche Pharmaceutical, Japan; Roche RX, Singapore



• Mabthera
  Roche, Sweden



• Reditux
  Dr Reddys, Vietnam



• Rituxan
  Biogen, United States; Genentech, United States; Roche, Canada; Zensei Yakuhin, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.